List of therapeutic monoclonal antibodies
From Infogalactic: the planetary knowledge core
This is a list of therapeutic, diagnostic and preventive monoclonal antibodies, antibodies which are clones of a single parent cell. When used as drugs, the International Nonproprietary Names (INNs) end in -mab. The remaining syllables of the INNs, as well as the column Source, are explained in Nomenclature of monoclonal antibodies.
The abbreviations in the column Type are as follows:
- mab: whole monoclonal antibody
- Fab: fragment, antigen-binding (one arm)
- F(ab')2: fragment, antigen-binding, including hinge region (both arms)
- Fab': fragment, antigen-binding, including hinge region (one arm)
- Variable fragments:
- scFv: single-chain variable fragment
- di-scFv: dimeric single-chain variable fragment
- sdAb: single-domain antibody
- Bispecific monoclonal antibodies:
- 3funct: trifunctional antibody
- BiTE: bi-specific T-cell engager
This list includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage.
Name | Trade name | Type | Source | Target | Use |
---|---|---|---|---|---|
3F8 | mab | mouse | GD2 | neuroblastoma | |
8H9[1] | mab | mouse | B7-H3 | neuroblastoma, sarcoma, metastatic brain cancers | |
Abagovomab[2] | mab | mouse | CA-125 (imitation) | ovarian cancer | |
Abciximab | ReoPro | Fab | chimeric | CD41 (integrin alpha-IIb) | platelet aggregation inhibitor |
Abituzumab[3] | mab | humanized | CD51 | cancer | |
Abrilumab[4] | mab | human | integrin α4β7 | inflammatory bowel disease, ulcerative colitis, Crohn's disease | |
Actoxumab[5] | mab | human | Clostridium difficile | Clostridium difficile infection | |
Adalimumab | Humira | mab | human | TNF-α | Rheumatoid arthritis, Crohn's Disease, Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hemolytic disease of the newborn |
Adecatumumab[6] | mab | human | EpCAM | prostate and breast cancer | |
Aducanumab[7] | mab | human | beta-amyloid | Alzheimer's disease | |
Afelimomab | F(ab')2 | mouse | TNF-α | sepsis | |
Afutuzumab[8] | mab | humanized | CD20 | lymphoma | |
Alacizumab pegol[9] | F(ab')2 | humanized | VEGFR2 | cancer | |
ALD518[10] | ? | humanized | IL-6 | rheumatoid arthritis | |
Alemtuzumab[11] | Campath, MabCampath | mab | humanized | CD52 | Multiple sclerosis |
Alirocumab[12] | mab | human | PCSK9 | hypercholesterolemia | |
Altumomab pentetate | Hybri-ceaker | mab | mouse | CEA | colorectal cancer (diagnosis) |
Amatuximab[13] | mab | chimeric | mesothelin | cancer | |
Anatumomab mafenatox | Fab | mouse | TAG-72 | non-small cell lung carcinoma | |
Anetumab ravtansine[3] | mab | human | MSLN | cancer | |
Anifrolumab[14] | mab | human | interferon α/β receptor | systemic lupus erythematosus | |
Anrukinzumab[9] (= IMA-638)[15] | mab | humanized | IL-13 | ? | |
Apolizumab[16] | mab | humanized | HLA-DR ? | hematological cancers | |
Arcitumomab | CEA-Scan | Fab' | mouse | CEA | gastrointestinal cancers (diagnosis) |
Ascrinvacumab[17] | mab | human | activin receptor-like kinase 1 | cancer | |
Aselizumab[18] | mab | humanized | L-selectin (CD62L) | severely injured patients | |
Atezolizumab[19] | mab | humanized | CD274 | cancer | |
Atinumab[20] | mab | human | RTN4 | ? | |
Atlizumab (= tocilizumab) | Actemra, RoActemra | mab | humanized | IL-6 receptor | rheumatoid arthritis |
Atorolimumab | mab | human | Rhesus factor | hemolytic disease of the newborn[citation needed] | |
Bapineuzumab[21] | mab | humanized | beta amyloid | Alzheimer's disease | |
Basiliximab | Simulect | mab | chimeric | CD25 (α chain of IL-2 receptor) | prevention of organ transplant rejections |
Bavituximab[2] | mab | chimeric | phosphatidylserine | cancer, viral infections | |
Bectumomab | LymphoScan | Fab' | mouse | CD22 | non-Hodgkin's lymphoma (detection) |
Begelomab[22] | mab | mouse | DPP4 | ? | |
Belimumab | Benlysta, LymphoStat-B | mab | human | BAFF | non-Hodgkin lymphoma etc. |
Benralizumab | mab | humanized | CD125 | asthma | |
Bertilimumab[18] | mab | human | CCL11 (eotaxin-1) | severe allergic disorders | |
Besilesomab[23] | Scintimun | mab | mouse | CEA-related antigen | inflammatory lesions and metastases (detection) |
Bevacizumab[11] | Avastin | mab | humanized | VEGF-A | metastatic cancer, retinopathy of prematurity |
Bezlotoxumab[24] | mab | human | Clostridium difficile | Clostridium difficile infection | |
Biciromab | FibriScint | Fab' | mouse | fibrin II, beta chain | thromboembolism (diagnosis) |
Bimagrumab[25][26] | mab | human | ACVR2B | myostatin inhibitor | |
Bimekizumab[27] | mab | humanized | IL17A and IL17F | ? | |
Bivatuzumab mertansine | mab | humanized | CD44 v6 | squamous cell carcinoma | |
Blinatumomab | BiTE | mouse | CD19 | cancer | |
Blosozumab[28] | mab | humanized | SOST | osteoporosis | |
Bococizumab[29] | mab | humanized | neural apoptosis-regulated proteinase 1 | dyslipidemia | |
Brentuximab vedotin[30] | mab | chimeric | CD30 (TNFRSF8) | hematologic cancers | |
Briakinumab[31] | mab | human | IL-12, IL-23 | psoriasis, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis | |
Brodalumab[32] | mab | human | IL-17 | inflammatory diseases | |
Brolucizumab[19] | mab | humanized | VEGFA | ? | |
Brontictuzumab[22] | mab | Notch 1 | cancer | ||
Canakinumab[33] | Ilaris | mab | human | IL-1? | rheumatoid arthritis |
Cantuzumab mertansine | mab | humanized | mucin CanAg | colorectal cancer etc. | |
Cantuzumab ravtansine[28] | mab | humanized | MUC1 | cancers | |
Caplacizumab[34] | mab | humanized | VWF | thrombotic thrombocytopenic purpura, thrombosis | |
Capromab pendetide | Prostascint | mab | mouse | prostatic carcinoma cells | prostate cancer (detection) |
Carlumab[35] | mab | human | MCP-1 | oncology/immune indications | |
Catumaxomab[21] | Removab | 3funct | rat/mouse hybrid | EpCAM, CD3 | ovarian cancer, malignant ascites, gastric cancer |
cBR96-doxorubicin immunoconjugate | mab | humanized | Lewis-Y antigen | cancer | |
Cedelizumab | mab | humanized | CD4 | prevention of organ transplant rejections, treatment of autoimmune diseases | |
Certolizumab pegol[6] | Cimzia | Fab' | humanized | TNF-α | Crohn's disease |
Cetuximab | Erbitux | mab | chimeric | EGFR | metastatic colorectal cancer and head and neck cancer |
Ch.14.18 [1] | mab | chimeric | ??? | neuroblastoma | |
Citatuzumab bogatox[8] | Fab | humanized | EpCAM | ovarian cancer and other solid tumors | |
Cixutumumab | mab | human | IGF-1 receptor | solid tumors | |
Clazakizumab[36] | mab | humanized | Oryctolagus cuniculus | rheumatoid arthritis | |
Clenoliximab | mab | chimeric | CD4 | rheumatoid arthritis | |
Clivatuzumab tetraxetan[37] | hPAM4-Cide | mab | humanized | MUC1 | pancreatic cancer |
Codrituzumab[3] | mab | humanized | glypican 3 | cancer | |
Coltuximab ravtansine[3] | mab | chimeric | CD19 | cancer | |
Conatumumab[8] | mab | human | TRAIL-R2 | cancer | |
Concizumab[25] | mab | humanized | TFPI | bleeding | |
Crenezumab[38] | mab | humanized | 1-40-β-amyloid | Alzheimer's disease | |
CR6261 | mab | human | Influenza A hemagglutinin | infectious disease/influenza A | |
Dacetuzumab[9] | mab | humanized | CD40 | hematologic cancers | |
Daclizumab | Zenapax | mab | humanized | CD25 (α chain of IL-2 receptor) | prevention of organ transplant rejections |
Dalotuzumab[39] | mab | humanized | insulin-like growth factor I receptor | cancer etc. | |
Dapirolizumab pegol[27] | mab | humanized | CD40 ligand | ? | |
Daratumumab[40] | mab | human | CD38 (cyclic ADP ribose hydrolase) | cancer | |
Dectrekumab[19] | mab | human | IL-13 | ? | |
Demcizumab[41] | mab | humanized | DLL4 | cancer | |
Denintuzumab mafodotin[22] | mab | humanized | CD19 | cancer | |
Denosumab[42] | Prolia | mab | human | RANKL | osteoporosis, bone metastases etc. |
Derlotuximab biotin[43] | mab | chimeric | histone complex | recurrent glioblastoma multiforme | |
Detumomab | mab | mouse | B-lymphoma cell | lymphoma | |
Dinutuximab[44] | mab | chimeric | ganglioside GD2 | neuroblastoma | |
Diridavumab[45] | mab | human | hemagglutinin | influenza A | |
Dorlimomab aritox[46] | F(ab')2 | mouse | ? | ? | |
Drozitumab[47] | mab | human | DR5 | cancer etc. | |
Duligotumab[48] | mab | human | HER3 | ? | |
Dupilumab[49] | mab | human | IL4 | atopic diseases | |
Durvalumab[50] | mab | human | CD274 | cancer | |
Dusigitumab[51] | mab | human | ILGF2 | cancer | |
Ecromeximab[16] | mab | chimeric | GD3 ganglioside | malignant melanoma | |
Eculizumab[16] | Soliris | mab | humanized | C5 | paroxysmal nocturnal hemoglobinuria |
Edobacomab | mab | mouse | endotoxin | sepsis caused by Gram-negative bacteria | |
Edrecolomab | Panorex | mab | mouse | EpCAM | colorectal carcinoma |
Efalizumab[52] | Raptiva | mab | humanized | LFA-1 (CD11a) | psoriasis (blocks T-cell migration) |
Efungumab[2] | Mycograb | scFv | human | Hsp90 | invasive Candida infection |
Eldelumab[53] | mab | human | interferon gamma-induced protein | Crohn's disease, ulcerative colitis | |
Elgemtumab[19] | mab | human | ERBB3 | cancer | |
Elotuzumab | mab | humanized | SLAMF7 | multiple myeloma | |
Elsilimomab | mab | mouse | IL-6 | ? | |
Emactuzumab[22] | mab | humanized | CSF1R | cancer | |
Emibetuzumab[54] | mab | humanized | HHGFR | cancer | |
Enavatuzumab[55] | mab | humanized | TWEAK receptor | cancer etc. | |
Enfortumab vedotin[56] | mab | human | AGS-22M6 | cancer expressing Nectin-4 | |
Enlimomab pegol[57] | mab | mouse | ICAM-1 (CD54) | ? | |
Enoblituzumab[58] | mab | humanized | B7-H3 | cancer | |
Enokizumab[59] | mab | humanized | IL9 | asthma | |
Enoticumab[48] | mab | human | DLL4 | ? | |
Ensituximab[60] | mab | chimeric | 5AC | cancer | |
Epitumomab cituxetan[61] | mab | mouse | episialin | ? | |
Epratuzumab | mab | humanized | CD22 | cancer, SLE | |
Erlizumab[62] | F(ab')2 | humanized | ITGB2 (CD18) | heart attack, stroke, traumatic shock | |
Ertumaxomab[21] | Rexomun | 3funct | rat/mouse hybrid | HER2/neu, CD3 | breast cancer etc. |
Etaracizumab | Abegrin | mab | humanized | integrin αvβ3 | melanoma, prostate cancer, ovarian cancer etc. |
Etrolizumab[63] | mab | humanized | integrin α7 β7 | inflammatory bowel disease | |
Evinacumab[64] | mab | human | angiopoietin 3 | dyslipidemia | |
Evolocumab[25] | mab | human | PCSK9 | hypercholesterolemia | |
Exbivirumab[65] | mab | human | hepatitis B surface antigen | hepatitis B | |
Fanolesomab[66] | NeutroSpec | mab | mouse | CD15 | appendicitis (diagnosis) |
Faralimomab | mab | mouse | interferon receptor | ? | |
Farletuzumab | mab | humanized | folate receptor 1 | ovarian cancer | |
Fasinumab[67] | mab | human | HNGF | acute sciatic pain | |
FBTA05[68][69] | Lymphomun | 3funct | rat/mouse hybrid | CD20 | chronic lymphocytic leukaemia |
Felvizumab | mab | humanized | respiratory syncytial virus | respiratory syncytial virus infection | |
Fezakinumab[70][71][72] | mab | human | IL-22 | rheumatoid arthritis, psoriasis | |
Ficlatuzumab[73] | mab | humanized | HGF | cancer etc. | |
Figitumumab | mab | human | IGF-1 receptor | adrenocortical carcinoma, non-small cell lung carcinoma etc. | |
Firivumab[22] | mab | human | influenza A virus hemagglutinin | ? | |
Flanvotumab[74] | mab | human | TYRP1(glycoprotein 75) | melanoma | |
Fletikumab[75] | mab | human | IL 20 | rheumatoid arthritis | |
Fontolizumab[16] | HuZAF | mab | humanized | IFN-γ | Crohn's disease etc. |
Foralumab[76] | mab | human | CD3 epsilon | ? | |
Foravirumab[8] | mab | human | rabies virus glycoprotein | rabies (prophylaxis) | |
Fresolimumab[77] | mab | human | TGF-β | idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, cancer | |
Fulranumab[78] | mab | human | NGF | pain | |
Futuximab[48] | mab | chimeric | EGFR | ? | |
Galiximab | mab | chimeric | CD80 | B-cell lymphoma | |
Ganitumab[79] | mab | human | IGF-I | cancer | |
Gantenerumab[33] | mab | human | beta amyloid | Alzheimer's disease | |
Gavilimomab[62] | mab | mouse | CD147 (basigin) | graft versus host disease | |
Gemtuzumab ozogamicin | Mylotarg | mab | humanized | CD33 | acute myelogenous leukemia |
Gevokizumab[80] | mab | humanized | IL-1β | diabetes etc. | |
Girentuximab[40] | Rencarex | mab | chimeric | carbonic anhydrase 9 (CA-IX) | clear cell renal cell carcinoma[81] |
Glembatumumab vedotin[82][83] | mab | human | GPNMB | melanoma, breast cancer | |
Golimumab[65] | Simponi | mab | human | TNF-α | rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis |
Gomiliximab | mab | chimeric | CD23 (IgE receptor) | allergic asthma | |
Guselkumab[84] | mab | human | IL23 | psoriasis | |
Ibalizumab[33] | mab | humanized | CD4 | HIV infection | |
Ibritumomab tiuxetan | Zevalin | mab | mouse | CD20 | non-Hodgkin's lymphoma |
Icrucumab[85] | mab | human | VEGFR-1 | cancer etc. | |
Idarucizumab[3] | mab | humanized | dabigatran | reversal of anticoagulant effects of dabigatran | |
Igovomab | Indimacis-125 | F(ab')2 | mouse | CA-125 | ovarian cancer (diagnosis) |
IMAB362 | mab | human | CLDN18.2 | gastrointestinal adenocarcinomas and pancreatic tumor | |
Imalumab[22] | mab | human | MIF | cancer | |
Imciromab | Myoscint | mab | mouse | cardiac myosin | cardiac imaging |
Imgatuzumab[48] | mab | humanized | EGFR | cancer | |
Inclacumab[34] | mab | human | selectin P | ? | |
Indatuximab ravtansine[28] | mab | chimeric | SDC1 | cancer | |
Indusatumab vedotin[19] | mab | human | GUCY2C | cancer | |
Infliximab | Remicade | mab | chimeric | TNF-α | rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis |
Intetumumab[86][87][88] | mab | human | CD51 | solid tumors (prostate cancer, melanoma) | |
Inolimomab | mab | mouse | CD25 (α chain of IL-2 receptor) | graft versus host disease | |
Inotuzumab ozogamicin[23] | mab | humanized | CD22 | cancer | |
Ipilimumab[42] | Yervoy | mab | human | CD152 | melanoma |
Iratumumab[42] | mab | human | CD30 (TNFRSF8) | Hodgkin's lymphoma | |
Isatuximab[89] | mab | chimeric | CD38 | cancer | |
Itolizumab[76] | mab | humanized | CD6 | ? | |
Ixekizumab[90] | mab | humanized | IL-17A | autoimmune diseases | |
Keliximab | mab | chimeric | CD4 | chronic asthma | |
Labetuzumab[52] | CEA-Cide | mab | humanized | CEA | colorectal cancer |
Lambrolizumab[91] | mab | humanized | PDCD1 | antineoplastic agent | |
Lampalizumab[48] | mab | humanized | CFD | ? | |
Lebrikizumab[92] | mab | humanized | IL-13 | asthma | |
Lemalesomab[62] | mab | mouse | NCA-90 (granulocyte antigen) | diagnostic agent | |
Lenzilumab[22] | mab | human | CSF2 | ? | |
Lerdelimumab[11] | mab | human | TGF beta 2 | reduction of scarring after glaucoma surgery | |
Lexatumumab[2] | mab | human | TRAIL-R2 | cancer | |
Libivirumab[65] | mab | human | hepatitis B surface antigen | hepatitis B | |
Lifastuzumab vedotin[93] | mab | humanized | phosphate-sodium co-transporter | cancer | |
Ligelizumab[48][94] | mab | humanized | IGHE | severe asthma and chronic spontaneous urticaria | |
Lilotomab satetraxetan[19] | mab | mouse | CD37 | cancer | |
Lintuzumab | mab | humanized | CD33 | cancer | |
Lirilumab[48] | mab | human | KIR2D | ? | |
Lodelcizumab[25] | mab | humanized | PCSK9 | hypercholesterolemia | |
Lokivetmab[19] | mab | veterinary | Canis lupus familiaris IL31 | ? | |
Lorvotuzumab mertansine | mab | humanized | CD56 | cancer | |
Lucatumumab[9] | mab | human | CD40 | multiple myeloma, non-Hodgkin's lymphoma, Hodgkin's lymphoma | |
Lulizumab pegol[95] | mab | humanized | CD28 | autoimmune diseases | |
Lumiliximab[6] | mab | chimeric | CD23 (IgE receptor) | chronic lymphocytic leukemia | |
Lumretuzumab[22] | mab | humanized | ERBB3 | cancer | |
Mapatumumab[21] | mab | human | TRAIL-R1 | cancer | |
Margetuximab[96] | mab | humanized | ch4D5 | cancer | |
Maslimomab | ? | mouse | T-cell receptor | ? | |
Mavrilimumab[97] | mab | human | GMCSF receptor α-chain | rheumatoid arthritis | |
Matuzumab[18] | mab | humanized | EGFR | colorectal, lung and stomach cancer | |
Mepolizumab | Bosatria | mab | humanized | IL-5 | asthma and white blood cell diseases |
Metelimumab[66] | mab | human | TGF beta 1 | systemic scleroderma | |
Milatuzumab[9] | mab | humanized | CD74 | multiple myeloma and other hematological malignancies | |
Minretumomab | mab | mouse | TAG-72 | tumor detection (and therapy?) | |
Mirvetuximab soravtansine[98] | mab | chimeric | folate receptor alpha | cancer | |
Mitumomab | mab | mouse | GD3 ganglioside | small cell lung carcinoma | |
Mogamulizumab[99] | mab | humanized | CCR4 | cancer | |
Morolimumab | mab | human | Rhesus factor | ? | |
Motavizumab[2] | Numax | mab | humanized | respiratory syncytial virus | respiratory syncytial virus (prevention) |
Moxetumomab pasudotox[100] | mab | mouse | CD22 | cancer | |
Muromonab-CD3 | Orthoclone OKT3 | mab | mouse | CD3 | prevention of organ transplant rejections |
Nacolomab tafenatox | Fab | mouse | C242 antigen | colorectal cancer | |
Namilumab[20] | mab | human | CSF2 | ? | |
Naptumomab estafenatox[101] | Fab | mouse | 5T4 | non-small cell lung carcinoma, renal cell carcinoma | |
Narnatumab[102] | mab | human | RON | cancer | |
Natalizumab | Tysabri | mab | humanized | integrin α4 | multiple sclerosis, Crohn's disease |
Nebacumab | mab | human | endotoxin | sepsis | |
Necitumumab[103] | mab | human | EGFR | non-small cell lung carcinoma | |
Nemolizumab[19] | mab | humanized | IL31RA | ? | |
Nerelimomab | mab | mouse | TNF-α | ? | |
Nesvacumab[104] | mab | human | angiopoietin 2 | cancer | |
Nimotuzumab[42][105] | Theracim, Theraloc | mab | humanized | EGFR | squamous cell carcinoma, head and neck cancer, nasopharyngeal cancer, glioma |
Nivolumab[106] | mab | human | PD-1 | cancer | |
Nofetumomab merpentan | Verluma | Fab | mouse | ? | cancer (diagnosis) |
Obiltoxaximab[107] | mab | chimeric | Bacillus anthracis anthrax | Bacillus anthracis spores | |
Obinutuzumab | Gazyva | mab | humanized | CD20 | Chronic lymphatic leukemia |
Ocaratuzumab[108] | mab | humanized | CD20 | cancer | |
Ocrelizumab[42] | mab | humanized | CD20 | rheumatoid arthritis, lupus erythematosus etc. | |
Odulimomab | mab | mouse | LFA-1 (CD11a) | prevention of organ transplant rejections, immunological diseases | |
Ofatumumab[21] | Arzerra | mab | human | CD20 | chronic lymphocytic leukemia etc. |
Olaratumab | mab | human | PDGF-R α | cancer | |
Olokizumab[76] | mab | humanized | IL6 | ? | |
Omalizumab[62] | Xolair | mab | humanized | IgE Fc region | allergic asthma |
Onartuzumab[109] | mab | humanized | human scatter factor receptor kinase | cancer | |
Ontuxizumab[110] | mab | chimeric/humanized | TEM1 | cancer | |
Opicinumab[111] | mab | human | LINGO-1 | multiple sclerosis | |
Oportuzumab monatox[103] | scFv | humanized | EpCAM | cancer | |
Oregovomab[66] | OvaRex | mab | mouse | CA-125 | ovarian cancer |
Orticumab[48] | mab | human | oxLDL | ? | |
Otelixizumab[9] | mab | chimeric/humanized | CD3 | diabetes mellitus type 1 | |
Otlertuzumab[112] | mab | humanized | CD37 | cancer | |
Oxelumab[113] | mab | human | OX-40 | asthma | |
Ozanezumab[114] | mab | humanized | NOGO-A | ALS and multiple sclerosis | |
Ozoralizumab[115] | mab | humanized | TNF-α | inflammation | |
Pagibaximab[21] | mab | chimeric | lipoteichoic acid | sepsis (Staphylococcus) | |
Palivizumab | Synagis, Abbosynagis | mab | humanized | F protein of respiratory syncytial virus | respiratory syncytial virus (prevention) |
Panitumumab[65] | Vectibix | mab | human | EGFR | colorectal cancer |
Pankomab | mab | humanized | tumor specific glycosylation of MUC1 | ovarian cancer | |
Panobacumab[103] | mab | human | Pseudomonas aeruginosa | Pseudomonas aeruginosa infection | |
Parsatuzumab[48] | mab | human | EGFL7 | cancer | |
Pascolizumab[16] | mab | humanized | IL-4 | asthma | |
Pasotuxizumab[22] | mab | chimeric/humanized | folate hydrolase | cancer | |
Pateclizumab[28] | mab | humanized | LTA | TNF | |
Patritumab[34] | mab | human | HER3 | cancer | |
Pembrolizumab[116] | mab | humanized | PDCD1 | cancer etc. | |
Pemtumomab | Theragyn | ? | mouse | MUC1 | cancer |
Perakizumab[48] | mab | humanized | IL17A | arthritis | |
Pertuzumab | Omnitarg | mab | humanized | HER2/neu | cancer |
Pexelizumab[52] | scFv | humanized | C5 | reduction of side effects of cardiac surgery | |
Pidilizumab[117] | mab | humanized | PD-1 | cancer and infectious diseases | |
Pinatuzumab vedotin[25] | mab | humanized | CD22 | cancer | |
Pintumomab | mab | mouse | adenocarcinoma antigen | adenocarcinoma (imaging) | |
Placulumab[118] | mab | human | human TNF | ? | |
Polatuzumab vedotin[25][119] | mab | humanized | CD79B | cancer | |
Ponezumab[120] | mab | humanized | human beta-amyloid | Alzheimer's disease | |
Priliximab | mab | chimeric | CD4 | Crohn's disease, multiple sclerosis | |
Pritoxaximab[25] | mab | chimeric | E. coli shiga toxin type-1 | ? | |
Pritumumab | mab | human | vimentin | brain cancer | |
PRO 140 | ? | humanized | CCR5 | HIV infection | |
Quilizumab[34] | mab | humanized | IGHE | asthma | |
Tetulomab | mab | humanized | CD37 | cancer[121] | |
Racotumomab[103] | mab | mouse | N-glycolylneuraminic acid | cancer | |
Radretumab[20] | mab | human | fibronectin extra domain-B | cancer | |
Rafivirumab[8] | mab | human | rabies virus glycoprotein | rabies (prophylaxis) | |
Ralpancizumab[122] | mab | humanized | neural apoptosis-regulated proteinase 1 | dyslipidemia | |
Ramucirumab | Cyramza | mab | human | VEGFR2 | solid tumors |
Ranibizumab[6] | Lucentis | Fab | humanized | VEGF-A | macular degeneration (wet form) |
Raxibacumab[23] | mab | human | anthrax toxin, protective antigen | anthrax (prophylaxis and treatment) | |
Refanezumab[123] | mab | humanized | myelin-associated glycoprotein | recovery of motor function after stroke | |
Regavirumab | mab | human | cytomegalovirus glycoprotein B | cytomegalovirus infection | |
Reslizumab[52] | mab | humanized | IL-5 | inflammations of the airways, skin and gastrointestinal tract | |
Rilotumumab[124] | mab | human | HGF | solid tumors | |
Rinucumab[125] | mab | human | platelet-derived growth factor receptor beta | neovascular age-related macular degeneration | |
Rituximab | MabThera, Rituxan | mab | chimeric | CD20 | lymphomas, leukemias, some autoimmune disorders |
Robatumumab | mab | human | IGF-1 receptor | cancer | |
Roledumab[76] | mab | human | RHD | ? | |
Romosozumab[126] | mab | humanized | sclerostin | osteoporosis | |
Rontalizumab[127] | mab | humanized | IFN-α | systemic lupus erythematosus | |
Rovelizumab | LeukArrest | mab | humanized | CD11, CD18 | haemorrhagic shock etc. |
Ruplizumab[11] | Antova | mab | humanized | CD154 (CD40L) | rheumatic diseases |
Sacituzumab govitecan[128] | mab | humanized | tumor-associated calcium signal transducer 2 | cancer | |
Samalizumab[129] | mab | humanized | CD200 | cancer | |
Sarilumab[130] | mab | human | IL6 | rheumatoid arthritis, ankylosing spondylitis | |
Satumomab pendetide | mab | mouse | TAG-72 | cancer (diagnosis) | |
Secukinumab[131] | mab | human | IL-17A | uveitis, rheumatoid arthritis psoriasis | |
Seribantumab[25] | mab | human | ERBB3 | cancer | |
Setoxaximab[25] | mab | chimeric | E. coli shiga toxin type-2 | ? | |
Sevirumab | ? | human | cytomegalovirus | cytomegalovirus infection | |
Sibrotuzumab | mab | humanized | FAP | cancer | |
SGN-CD19A | mab | humanized | CD19 | acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma | |
SGN-CD33A | mab | humanized | CD33 | Acute myeloid leukemia | |
Sifalimumab[132] | mab | humanized | IFN-α | SLE, dermatomyositis, polymyositis | |
Siltuximab | mab | chimeric | IL-6 | cancer | |
Simtuzumab[48] | mab | humanized | LOXL2 | fibrosis | |
Siplizumab[16] | mab | humanized | CD2 | psoriasis, graft-versus-host disease (prevention) | |
Sirukumab[133] | mab | human | IL-6 | rheumatoid arthritis | |
Sofituzumab vedotin[134] | mab | humanized | CA 125 | ovarian cancer | |
Solanezumab[103] | mab | humanized | beta amyloid | Alzheimer's disease | |
Solitomab[34] | mab | mouse | EpCAM | ? | |
Sonepcizumab[135] | ? | humanized | sphingosine-1-phosphate | choroidal and retinal neovascularization | |
Sontuzumab[105] | mab | humanized | episialin | ? | |
Stamulumab[42][105] | mab | human | myostatin | muscular dystrophy | |
Sulesomab | LeukoScan | Fab' | mouse | NCA-90 (granulocyte antigen) | osteomyelitis (imaging) |
Suvizumab[82] | mab | humanized | HIV-1 | viral infections | |
Tabalumab[136] | mab | human | BAFF | B-cell cancers | |
Tacatuzumab tetraxetan | AFP-Cide | mab | humanized | alpha-fetoprotein | cancer |
Tadocizumab[105] | Fab | humanized | integrin αIIbβ3 | percutaneous coronary intervention | |
Talizumab | mab | humanized | IgE | allergic reaction | |
Tanezumab[8] | mab | humanized | NGF | pain | |
Taplitumomab paptox[62] | mab | mouse | CD19 | cancer[citation needed] | |
Tarextumab[137] | mab | human | Notch receptor | cancer | |
Tefibazumab[23] | Aurexis | mab | humanized | clumping factor A | Staphylococcus aureus infection |
Telimomab aritox | Fab | mouse | ? | ? | |
Tenatumomab[9] | mab | mouse | tenascin C | cancer | |
Teneliximab[16] | mab | chimeric | CD40 | ? | |
Teplizumab[33] | mab | humanized | CD3 | diabetes mellitus type 1 | |
Teprotumumab[138] | mab | human | CD221 | hematologic tumors | |
Tesidolumab[19] | mab | human | C5 | ? | |
TGN1412 | ? | humanized | CD28 | chronic lymphocytic leukemia, rheumatoid arthritis | |
Ticilimumab (= tremelimumab) | mab | human | CTLA-4 | cancer | |
Tildrakizumab[139] | mab | humanized | IL23 | immunologically mediated inflammatory disorders | |
Tigatuzumab[9] | mab | humanized | TRAIL-R2 | cancer | |
TNX-650 | ? | humanized | IL-13 | Hodgkin's lymphoma | |
Tocilizumab[6] (= atlizumab) | Actemra, RoActemra | mab | humanized | IL-6 receptor | rheumatoid arthritis |
Toralizumab[16] | mab | humanized | CD154 (CD40L) | rheumatoid arthritis, lupus nephritis etc. | |
Tosatoxumab[3] | mab | human | Staphylococcus aureus | ? | |
Tositumomab | Bexxar | ? | mouse | CD20 | follicular lymphoma |
Tovetumab[140] | mab | human | CD140a | cancer | |
Tralokinumab[141] | mab | human | IL-13 | asthma etc. | |
Trastuzumab | Herceptin | mab | humanized | HER2/neu | breast cancer |
TRBS07[142] | Ektomab | 3funct | ? | GD2 | melanoma |
Tregalizumab[20] | mab | humanized | CD4 | ? | |
Tremelimumab | mab | human | CTLA-4 | cancer | |
Trevogrumab[143] | mab | human | growth differentiation factor 8 | muscle atrophy due to orthopedic disuse and sarcopenia | |
Tucotuzumab celmoleukin[42][105] | mab | humanized | EpCAM | cancer | |
Tuvirumab | ? | human | hepatitis B virus | chronic hepatitis B | |
Ublituximab[20] | mab | chimeric | MS4A1 | cancer | |
Ulocuplumab[144] | mab | human | C-X-C chemokine receptor type 4 | hematologic malignancies | |
Urelumab[145] | mab | human | 4-1BB | cancer etc. | |
Urtoxazumab[6] | mab | humanized | Escherichia coli | diarrhoea caused by E. coli | |
Ustekinumab[8] | Stelara | mab | human | IL-12, IL-23 | multiple sclerosis, psoriasis, psoriatic arthritis |
Vandortuzumab vedotin[19] | mab | humanized | STEAP1 | cancer | |
Vantictumab[146] | mab | human | Frizzled receptor | cancer | |
Vanucizumab[22] | mab | humanized | angiopoietin 2 | cancer | |
Vapaliximab[16] | mab | chimeric | AOC3 (VAP-1) | ? | |
Varlilumab[147] | mab | human | CD27 | ? | |
Vatelizumab[28] | mab | humanized | ITGA2 | ? | |
Vedolizumab | mab | humanized | integrin α4β7 | Crohn's disease, ulcerative colitis | |
Veltuzumab[9] | mab | humanized | CD20 | non-Hodgkin's lymphoma | |
Vepalimomab | mab | mouse | AOC3 (VAP-1) | inflammation | |
Vesencumab[20] | mab | human | NRP1 | ? | |
Visilizumab[62] | Nuvion | mab | humanized | CD3 | Crohn's disease, ulcerative colitis |
Volociximab[21] | mab | chimeric | integrin α5β1 | solid tumors | |
Vorsetuzumab mafodotin[148] | mab | humanized | CD70 | cancer | |
Votumumab | HumaSPECT | mab | human | tumor antigen CTAA16.88 | colorectal tumors |
Zalutumumab[21] | HuMax-EGFr | mab | human | EGFR | squamous cell carcinoma of the head and neck |
Zanolimumab[6] | HuMax-CD4 | mab | human | CD4 | rheumatoid arthritis, psoriasis, T-cell lymphoma |
Zatuximab[48] | mab | chimeric | HER1 | cancer | |
Ziralimumab[62] | mab | human | CD147 (basigin) | ? | |
Zolimomab aritox | mab | mouse | CD5 | systemic lupus erythematosus, graft-versus-host disease |
References
- ↑ 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 2.0 2.1 2.2 2.3 2.4 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 8.0 8.1 8.2 8.3 8.4 8.5 8.6 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 9.0 9.1 9.2 9.3 9.4 9.5 9.6 9.7 9.8 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 11.0 11.1 11.2 11.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 16.0 16.1 16.2 16.3 16.4 16.5 16.6 16.7 16.8 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 18.0 18.1 18.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 19.0 19.1 19.2 19.3 19.4 19.5 19.6 19.7 19.8 19.9 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 20.0 20.1 20.2 20.3 20.4 20.5 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 21.0 21.1 21.2 21.3 21.4 21.5 21.6 21.7 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 22.0 22.1 22.2 22.3 22.4 22.5 22.6 22.7 22.8 22.9 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 23.0 23.1 23.2 23.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 25.0 25.1 25.2 25.3 25.4 25.5 25.6 25.7 25.8 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 27.0 27.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 28.0 28.1 28.2 28.3 28.4 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 33.0 33.1 33.2 33.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 34.0 34.1 34.2 34.3 34.4 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 40.0 40.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 42.0 42.1 42.2 42.3 42.4 42.5 42.6 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 48.00 48.01 48.02 48.03 48.04 48.05 48.06 48.07 48.08 48.09 48.10 48.11 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 52.0 52.1 52.2 52.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 62.0 62.1 62.2 62.3 62.4 62.5 62.6 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 65.0 65.1 65.2 65.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 66.0 66.1 66.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Clinical trial number NCT00883896 for "Study to Evaluate the Safety and Efficacy of ILV-094 in Subjects With Rheumatoid Arthritis" at ClinicalTrials.gov
- ↑ Clinical trial number NCT00563524 for "Study Evaluating the Safety and Tolerability of ILV-094 in Subjects With Psoriasis" at ClinicalTrials.gov
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 76.0 76.1 76.2 76.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ http://www.prnewswire.com/news-releases/prometheus-obtains-exclusive-us-commercialization-rights-for-rencarex-121075044.html
- ↑ 82.0 82.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ NCI Drug Dictionary: Glemtumumab vedotin
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Clinical trial number NCT00537381 for "A Study of the Safety and Effectiveness of CNTO 95 in Patients With Metastatic Hormone Refractory Prostate Cancer" at ClinicalTrials.gov
- ↑ Clinical trial number NCT00246012 for "A Study of the Safety and Efficacy CNTO 95 in Subjects With Advanced Melanoma" at ClinicalTrials.gov
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 103.0 103.1 103.2 103.3 103.4 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 105.0 105.1 105.2 105.3 105.4 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.